Table 1 Site selection criteria.

From: Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design

Site selection criteria

 Having access to AF patients undergoing PCI (≥ 20 patients in the planned recruitment time)

 Having patients treated with edoxaban

 Agreeing to follow-up each patient for approximately a 1-year period according to a clinical routine, performing structured phone interviews ca. 1-month and 1-year after successful PCI

 Being able to document data in English language

 Being able to complete the study using the electronic data capturing system

 Being able to conduct the study adequately, with enough time and staff to identify eligible patients, conduct the patient consent process, participate in required trainings, and follow-up with study-related activities

  1. PCI percutaneous coronary intervention.
Back to article page